Sanofi SA vs Block Inc — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Block Inc trades at $80.35 (market cap $47.19B). The key difference: Sanofi SA is far larger — about 2.2× Block Inc's market cap, and Sanofi SA pays a 5.5% dividend while Block Inc pays none. Which is the better fit depends on your goals.
| SNY | XYZ | |
|---|---|---|
Market Cap | $104.83B | $47.19B |
Sector | Health | Technology |
52-Week High | $52.34 | $81.81 |
52-Week Low | $41.33 | $49.04 |
Enterprise Value | $121.32B | $42.06B |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →